British American Tobacco p.l.c. : Back on key levels based on weekly price data
| Entry price | Target | Stop-loss | Potential |
|---|
|
GBX 2,627 |
GBX 2,870 |
GBX 2,491.5 |
+9.25% |
|---|
Technically, timing appears good within a medium term time horizon to buy shares in British American Tobacco Plc. The technical support area at 2491.5 GBX effectively limits downside risk and should allow the stock to get back into an upward dynamic.
Strengths● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
● Its low valuation, with P/E ratio at 8.54 and 8.14 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
● This company will be of major interest to investors in search of a high dividend stock.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● One of the major weak points of the company is its financial situation.
● The underlying tendency is negative on the weekly chart below the resistance at 2945.5 GBX
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
BRITISH AMERICAN TOBACCO P.L.C. 
